These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6124830)

  • 1. Ketanserin in acute superficial thrombophlebitis.
    de Roose J; Symoens J
    Lancet; 1982 Aug; 2(8295):440-1. PubMed ID: 6124830
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
    Weiner CP; Socol ML; Vaisrub N
    Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketanserin (5 HT2-antagonist) in secondary Raynaud's phenomenon.
    Bounameaux HM; Hellemans H; Verhaeghe R; Dequeker J
    J Cardiovasc Pharmacol; 1984; 6(5):975-6. PubMed ID: 6209510
    [No Abstract]   [Full Text] [Related]  

  • 4. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
    Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G
    Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173
    [No Abstract]   [Full Text] [Related]  

  • 5. Placebo-controlled, double-blind, two-centre trial of ketanserin in intermittent claudication.
    Bounameaux H; Holditch T; Hellemans H; Berent A; Verhaeghe R
    Lancet; 1985 Dec; 2(8467):1268-71. PubMed ID: 2866336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome.
    Prescott RW; Ratcliffe WA; Taylor PK
    Br Med J (Clin Res Ed); 1984 Sep; 289(6448):787-8. PubMed ID: 6089950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketanserin in chronic sympathetic dystrophy. An acute controlled trial.
    Bounameaux HM; Hellemans H; Verhaeghe R
    Clin Rheumatol; 1984 Dec; 3(4):556-7. PubMed ID: 6084577
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study with the competitive 5-HT2-serotonergic antagonist ketanserin.
    Ferrara LA; Fasano ML; Rubba P; Soro S; Marotta G; Mancini M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S159-60. PubMed ID: 2412041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of serotonergic blockade in postpartum preeclamptic patients.
    Montenegro R; Knuppel RA; Shah D; O'Brien WF
    Am J Obstet Gynecol; 1985 Sep; 153(2):130-4. PubMed ID: 2931024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication.
    De Cree J; Leempoels J; Geukens H; Verhaegen H
    Lancet; 1984 Oct; 2(8406):775-9. PubMed ID: 6148522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders.
    Roald OK; Seem E
    Br Med J (Clin Res Ed); 1984 Sep; 289(6445):577-9. PubMed ID: 6432198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
    Rosenthal J; Koehle W; Gruebel B; Fisher R
    J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ketanserin a D receptor antagonist?
    Lancet; 1983 Mar; 1(8326 Pt 1):703-4. PubMed ID: 6132056
    [No Abstract]   [Full Text] [Related]  

  • 16. Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial.
    Gustafsen J; Lendorf A; Raskov H; Boesby S
    Scand J Gastroenterol; 1986 Sep; 21(7):816-8. PubMed ID: 3535008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies with ketanserin in hypertension.
    Waal-Manning HJ; Brown SA; Spears GF; Simpson FO
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S154-8. PubMed ID: 2412040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
    De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
    Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with ketanserin, a serotonin (S2) antagonist, in longterm treatment of essential hypertension.
    Hedner T; Persson B; Berglund G
    Clin Exp Hypertens A; 1984; 6(3):743-51. PubMed ID: 6373066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra arterial ketanserin in peripheral vascular disease.
    Boas RA
    Angiology; 1986 Apr; 37(4):267-71. PubMed ID: 2940946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.